Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study

Clinical trial NCT02279602 · COMPLETED

Trial details

NCT number: NCT02279602
Sponsor: Mateon Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2014-12-01
Primary completion: 2016-08-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.